File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: COX-2 inhibition in combination with preoperative chemoradiation for CA esophagus

TitleCOX-2 inhibition in combination with preoperative chemoradiation for CA esophagus
Authors
Kwong, DLLaw, SYTong, DKHWong, KHNicholls, J
KeywordsMedical sciences
Oncology medical sciences
Radiology and nuclear medicine pharmacy and pharmacology biology
Cytology and histology
Issue Date2009
PublisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/
Citation
The 45th Annual Meeting of the American Society of Clinical Oncology (ASCO 2009), Orlando, FL., 29 May-2 June 2009. In Journal of Clinical Oncology, 2009, v. 27 n. 15S, abstract no. e15607 How to Cite?
AbstractBACKGROUND: Squamous cell carcinoma of the thoracic esophagus (ESCC) is often diagnosed in advanced stage. Pre-operative chemoradiation is employed to downstage the disease before operation. Pathological complete response (pCR) was observed in around 20–40% of patients and was associated with improved survival. Cyclooxygenase 2 (COX-2) is overexpressed in ESCC and may contribute to chemo- and radio-resistance. This pilot study evaluates ...
DescriptionThis abstract will not be presented at the 2009 ASCO Annual Meeting but has been published in conjunction with the meeting.
This journal suppl. entitled: ASCO Meeting Abstracts Part 1
Persistent Identifierhttp://hdl.handle.net/10722/62726
ISSN
0732-183X
2023 Impact Factor: 42.1
2023 SCImago Journal Rankings: 10.639

 

DC FieldValueLanguage
dc.contributor.authorKwong, DLen_HK
dc.contributor.authorLaw, SYen_HK
dc.contributor.authorTong, DKHen_HK
dc.contributor.authorWong, KHen_HK
dc.contributor.authorNicholls, Jen_HK
dc.date.accessioned2010-07-13T04:07:51Z-
dc.date.available2010-07-13T04:07:51Z-
dc.date.issued2009en_HK
dc.identifier.citationThe 45th Annual Meeting of the American Society of Clinical Oncology (ASCO 2009), Orlando, FL., 29 May-2 June 2009. In Journal of Clinical Oncology, 2009, v. 27 n. 15S, abstract no. e15607-
dc.identifier.issn0732-183X-
dc.identifier.urihttp://hdl.handle.net/10722/62726-
dc.descriptionThis abstract will not be presented at the 2009 ASCO Annual Meeting but has been published in conjunction with the meeting.en_HK
dc.descriptionThis journal suppl. entitled: ASCO Meeting Abstracts Part 1-
dc.description.abstractBACKGROUND: Squamous cell carcinoma of the thoracic esophagus (ESCC) is often diagnosed in advanced stage. Pre-operative chemoradiation is employed to downstage the disease before operation. Pathological complete response (pCR) was observed in around 20–40% of patients and was associated with improved survival. Cyclooxygenase 2 (COX-2) is overexpressed in ESCC and may contribute to chemo- and radio-resistance. This pilot study evaluates ...-
dc.languageengen_HK
dc.publisherAmerican Society of Clinical Oncology. The Journal's web site is located at http://www.jco.org/-
dc.relation.ispartofJournal of Clinical Oncology-
dc.subjectMedical sciences-
dc.subjectOncology medical sciences-
dc.subjectRadiology and nuclear medicine pharmacy and pharmacology biology-
dc.subjectCytology and histology-
dc.titleCOX-2 inhibition in combination with preoperative chemoradiation for CA esophagusen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailKwong, DL: dlwkwong@hku.hken_HK
dc.identifier.emailLaw, SY: slaw@hku.hken_HK
dc.identifier.emailTong, DKH: esodtong@hku.hken_HK
dc.identifier.emailNicholls, J: jmnichol@hkucc.hku.hk-
dc.identifier.authorityKwong, DL=rp00414en_HK
dc.identifier.authorityLaw, SY=rp00437en_HK
dc.identifier.authorityNicholls, J=rp00364en_HK
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros166451en_HK
dc.identifier.hkuros166695-
dc.identifier.volume27-
dc.identifier.issue15 suppl.-
dc.publisher.placeUnited States-
dc.identifier.issnl0732-183X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats